Seeking Alpha

Covidien (COV +2.2%) trades higher after announcing the FDA has issued a clearance for the...

Covidien (COV +2.2%) trades higher after announcing the FDA has issued a clearance for the company's SpiderFX, an embolic protection device for the treatment of severely calcified arterial lesions in the lower extremities.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)